Advertisement
Screener

LENZ THERAPEUTICS, INC. (LENZ) ROA

LENZ THERAPEUTICS, INC. (LENZ) ROA

  • 2026-06-30: ROA -53.26%.
  • 2026-03-31: ROA -39.99%.
  • 2025-12-31: ROA -26.85%.
  • 2025-09-30: ROA -27.95%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-53.26%
2026-03-31-39.99%
2025-12-31-26.85%
2025-09-30-27.95%
2025-06-30-24.11%
2025-03-31-23.72%
2024-12-31-23.12%
2024-09-30-27.15%
2024-06-30-34.28%
2024-03-31-34.03%
2023-12-31-99.42%
2023-09-30-26.62%
2023-06-30-26.71%
2023-03-31-28.35%
2022-12-31-31.39%
2022-09-30-28.49%
2022-06-30-24.11%
2022-03-31-20.31%
2021-12-31-17.60%
2021-09-30-27.72%
2021-06-30-26.91%

Annual ROA

DateROA
2025-12-31-26.85%
2024-12-31-23.12%
2023-12-31-99.42%
2022-12-31-31.39%
2021-12-31-17.60%
2020-12-31-303.02%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48